Variant report
Variant | nsv817855 |
---|---|
Chromosome Location | chr19:51260989-51263510 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:126)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF3 | chr19:51263161-51263447 | K562 | blood: | n/a | n/a |
2 | ATF3 | chr19:51263137-51263443 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | ATF3 | chr19:51263192-51263431 | GM12878 | blood: | n/a | n/a |
4 | CBX3 | chr19:51263013-51263594 | K562 | blood: | n/a | n/a |
5 | CEBPB | chr19:51263101-51263642 | A549 | lung: | n/a | chr19:51263448-51263459 |
6 | CEBPB | chr19:51263204-51263640 | MCF-7 | breast: | n/a | chr19:51263448-51263459 |
7 | CEBPB | chr19:51263262-51263640 | IMR90 | lung: | n/a | chr19:51263448-51263459 |
8 | CEBPB | chr19:51263273-51263642 | ECC-1 | luminal epithelium: | n/a | chr19:51263448-51263459 |
9 | CEBPB | chr19:51263261-51263636 | HepG2 | liver: | n/a | chr19:51263448-51263459 |
10 | CEBPB | chr19:51263175-51263636 | Hela-S3 | cervix: | n/a | chr19:51263448-51263459 |
11 | CEBPB | chr19:51263228-51263684 | A549 | lung: | n/a | chr19:51263448-51263459 |
12 | CEBPB | chr19:51263149-51263649 | K562 | blood: | n/a | chr19:51263448-51263459 |
13 | CEBPB | chr19:51263143-51263622 | K562 | blood: | n/a | chr19:51263448-51263459 |
14 | CEBPB | chr19:51263301-51263537 | K562 | blood: | n/a | chr19:51263448-51263459 |
15 | CEBPB | chr19:51263182-51263643 | A549 | lung: | n/a | chr19:51263448-51263459 |
16 | CEBPB | chr19:51263226-51263641 | H1-hESC | embryonic stem cell: | n/a | chr19:51263448-51263459 |
17 | CEBPB | chr19:51263161-51263648 | MCF-7 | breast: | n/a | chr19:51263448-51263459 |
18 | CEBPB | chr19:51263279-51263520 | ECC-1 | luminal epithelium: | n/a | chr19:51263448-51263459 |
19 | CHD2 | chr19:51263138-51263480 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | CHD2 | chr19:51263145-51263466 | K562 | blood: | n/a | n/a |
21 | ELF1 | chr19:51263226-51263485 | GM12878 | blood: | n/a | n/a |
22 | ELF1 | chr19:51263180-51263554 | A549 | lung: | n/a | n/a |
23 | ELF1 | chr19:51263160-51263539 | MCF-7 | breast: | n/a | n/a |
24 | ELF1 | chr19:51263104-51263493 | A549 | lung: | n/a | n/a |
25 | ELF1 | chr19:51263195-51263521 | SK-N-SH | brain: | n/a | n/a |
26 | ELF1 | chr19:51263096-51263583 | K562 | blood: | n/a | n/a |
27 | ELF1 | chr19:51262976-51263639 | HCT-116 | colon: | n/a | n/a |
28 | ELF1 | chr19:51263221-51263490 | K562 | blood: | n/a | n/a |
29 | EP300 | chr19:51263177-51263465 | K562 | blood: | n/a | n/a |
30 | ETS1 | chr19:51263085-51263506 | A549 | lung: | n/a | n/a |
31 | ETS1 | chr19:51263096-51263444 | A549 | lung: | n/a | n/a |
32 | FOS | chr19:51263139-51263507 | K562 | blood: | n/a | n/a |
33 | FOXA2 | chr19:51262281-51262789 | A549 | lung: | n/a | n/a |
34 | HCFC1 | chr19:51263086-51263540 | K562 | blood: | n/a | n/a |
35 | HCFC1 | chr19:51262953-51263595 | Hela-S3 | cervix: | n/a | n/a |
36 | IRF1 | chr19:51263147-51263495 | K562 | blood: | n/a | n/a |
37 | IRF1 | chr19:51263115-51263527 | K562 | blood: | n/a | n/a |
38 | IRF3 | chr19:51263211-51263348 | GM12878 | blood: | n/a | n/a |
39 | JUND | chr19:51263188-51263476 | K562 | blood: | n/a | n/a |
40 | MAX | chr19:51262978-51263464 | K562 | blood: | n/a | chr19:51263302-51263312 |
41 | MAX | chr19:51263174-51263478 | A549 | lung: | n/a | chr19:51263302-51263312 |
42 | MAX | chr19:51263123-51263421 | K562 | blood: | n/a | chr19:51263302-51263312 |
43 | MAX | chr19:51263113-51263491 | NB4 | blood: | n/a | chr19:51263302-51263312 |
44 | MAX | chr19:51263202-51263447 | GM12878 | blood: | n/a | chr19:51263302-51263312 |
45 | MAX | chr19:51263139-51263485 | K562 | blood: | n/a | chr19:51263302-51263312 |
46 | MAX | chr19:51263134-51263482 | H1-hESC | embryonic stem cell: | n/a | chr19:51263302-51263312 |
47 | MAX | chr19:51263122-51263484 | K562 | blood: | n/a | chr19:51263302-51263312 |
48 | MYC | chr19:51263163-51263421 | NB4 | blood: | n/a | chr19:51263302-51263312 |
49 | MYC | chr19:51263106-51263486 | K562 | blood: | n/a | chr19:51263302-51263312 |
50 | MYC | chr19:51263073-51263464 | K562 | blood: | n/a | chr19:51263302-51263312 |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:51261730..51264544-chr19:51297937..51299631,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GPR32P1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7245984 | chr19:51260989-51260990 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs200773575 | chr19:51261048-51261049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7246110 | chr19:51261051-51261052 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs114451447 | chr19:51261075-51261076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576469630 | chr19:51261085-51261086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7246125 | chr19:51261095-51261096 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs555824491 | chr19:51261108-51261109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574641215 | chr19:51261133-51261134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542147758 | chr19:51261145-51261146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560049288 | chr19:51261146-51261147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572209108 | chr19:51261173-51261174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545553204 | chr19:51261209-51261210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563856056 | chr19:51261210-51261211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531340459 | chr19:51261251-51261252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372790573 | chr19:51261260-51261261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146065264 | chr19:51261274-51261275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189242303 | chr19:51261281-51261282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548069466 | chr19:51261329-51261330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149510523 | chr19:51261339-51261340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143115148 | chr19:51261342-51261343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138876408 | chr19:51261383-51261384 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs193099312 | chr19:51261386-51261387 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs374665601 | chr19:51261395-51261396 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs374700998 | chr19:51261396-51261397 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs202184085 | chr19:51261408-51261409 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs376978246 | chr19:51261410-51261411 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs146327260 | chr19:51261411-51261412 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs535343242 | chr19:51261424-51261425 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs535231459 | chr19:51261433-51261434 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs185119552 | chr19:51261448-51261449 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs545580117 | chr19:51261466-51261467 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs557561252 | chr19:51261472-51261473 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs112233711 | chr19:51261507-51261508 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs568502652 | chr19:51261522-51261523 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs372086691 | chr19:51261546-51261547 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs561310778 | chr19:51261564-51261565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376075025 | chr19:51261624-51261625 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs73046514 | chr19:51261635-51261636 | Strong transcription Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs141836767 | chr19:51261645-51261646 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs112749815 | chr19:51261654-51261655 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570310740 | chr19:51261684-51261685 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139938743 | chr19:51261735-51261736 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs116022451 | chr19:51261744-51261745 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs371890980 | chr19:51261747-51261748 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567517741 | chr19:51261769-51261770 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575030665 | chr19:51261795-51261796 | Strong transcription Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs117611112 | chr19:51261825-51261826 | Enhancers Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs188996701 | chr19:51261828-51261829 | Enhancers Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73046516 | chr19:51261829-51261830 | Enhancers Genic enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs557524811 | chr19:51261841-51261842 | Enhancers Genic enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17160897 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Lung cancer | 18438408 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:51243800-51261600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr19:51252200-51263000 | Weak transcription | K562 | blood |
3 | chr19:51260200-51261600 | Weak transcription | Placenta | Placenta |
4 | chr19:51261600-51261800 | Strong transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr19:51261600-51268000 | Enhancers | Placenta | Placenta |
6 | chr19:51261800-51262000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr19:51261800-51262000 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr19:51262000-51262200 | Strong transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr19:51262000-51263000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr19:51262200-51273800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr19:51263000-51263200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr19:51263000-51264600 | Enhancers | K562 | blood |